You searched for Antibody candidate - Page 39 of 69

News and Trends 16 Dec 2022

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

…to accelerate development of our antibody and deliver some hope for patients.” This is the second grant awarded to Alchemab and MDC. The financing will support preclinical development of the…

December 16, 2022 - 3 minutesmins - By Jim Cornall

More News! 17 Oct 2022

Clinical trial of treatment for advanced solid tumors approved

…about a phase 1b/2 clinical trial of its in-house developed Ivonescimab (PD-1/VEGF bi-specific AK112) combined with Drebuxelimab (CD73, AK119). AK112 is the first PD-1/VEGF bi-specific antibody that entered phase 3…

October 17, 2022 - 2 minutesmins - By Liza Laws

geneuro multiple sclerosis neuron viral dna

News and Trends 12 Mar 2019

Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis

An antibody that blocks the action of a hidden viral protein encoded by our genome shows encouraging signs of slowing down the progression of multiple sclerosis, according to the Swiss…

March 12, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Jun 2016

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

…through other methods. Numab then engineers these antibody’s variable domain (the part of the antibody with binds to antigen) to make it more stable and then uses it as a…

June 6, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 15 Oct 2020

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

…approach to Alexion and the other antibody developers, whose drugs require intravenous injection. The company also targets another rare neuromuscular condition, myasthenia gravis, with the same drug candidate. “Chord Therapeutics…

October 15, 2020 - 3 minutesmins - By Helen Albert

pure biologics wroclaw devics disease 1 1

Startup Scout 31 May 2019

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

…begin clinical trials in 2023. Pure Biologics also has a separate program developing an antibody drug that binds two targets at once, called a bispecific antibody. Although there are other…

May 31, 2019 - 4 minutesmins - By Jonathan Smith

News and Trends 28 Sep 2018

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

…cells called regulatory T cells. These cells hold back the immune system from attacking tumors, thus the antibody helps the patient’s immune system to fight the cancer. The antibody has…

September 28, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Feb 2023

Maxion Therapeutics raises $16M to target GPCRs

…co-founded CAT (acquired by AstraZeneca for £700 million) and IONTAS (acquired by FairJourney Biologics). At CAT, McCafferty co-invented antibody phage display, the technology used to discover the world’s best-selling drug,…

February 16, 2023 - 3 minutesmins - By Jim Cornall

More News! 29 Sep 2022

Positive results from Eisai and Biogen Alzheimer’s trial

…antibody. It met the primary endpoint and all key secondary endpoints with highly statistically significant results. Lecanemab is an investigational humanized monoclonal antibody for AD that is the result of…

September 29, 2022 - 6 minutesmins - By Jim Cornall

In Depth 5 Feb 2024

Future of cancer treatment: what will therapy look like in 2034?

…the clinic. Maher expects antibody-based therapeutics to continue to yield new drugs like immunomodulatory agents and antibody drug conjugates “that deliver ever more powerful poisons in a selective manner to…

February 5, 2024 - 10 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Jun 2025

Life sciences in Wales: biotechs in the scene in 2025

…Antiverse Founded in 2017 Technology: Antibody discovery and development Latest funding: $4.6 million investment AI has accelerated innovation in the world of biotech. Over the years, it has bolstered antibody…

June 30, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 19 Nov 2016

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

…therapeutic antibody’s development due to the similarity of the cells to human cells (e.g. folding, glycosylation etc). For example, CHO-K1-based cell lines, derived from the ovarian cells of the Chinese…

November 19, 2016 - 4 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Alchemab Therapeutics receives £1.7M grant to work on therapy for Huntington’s disease

Clinical trial of treatment for advanced solid tumors approved

Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

Maxion Therapeutics raises $16M to target GPCRs

Positive results from Eisai and Biogen Alzheimer’s trial

Future of cancer treatment: what will therapy look like in 2034?

Life sciences in Wales: biotechs in the scene in 2025

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!